Dunne RB and Shortt S. Am J Emerg Med. 2018 Apr;36(4):641-646.
In this month's Clinical Spotlight: Dunne et al. showed that 85% of patients treated with a vibrating mesh nebulizer achieved symptom control with a single bronchodilator dose. (Dunne & Shorrt)
